Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Villert, A."'
Autor:
O. N. Churuksaeva, L. A. Kolomiets, A. L. Chernyshova, A. B. Villert, M. O. Ochirov, Yu. M. Trushchuk, A. A. Maltseva, L. A. Tashireva
Publikováno v:
Сибирский онкологический журнал, Vol 23, Iss 2, Pp 26-36 (2024)
Background. Determination of the feasibility of performing minimally invasive surgery for invasive cervical cancer and identification of criteria for optimal surgical access that ensures safety, effectiveness, and satisfactory immediate and long-term
Externí odkaz:
https://doaj.org/article/2608289d90864189b3b25fd522fea45a
Autor:
A. A. Maltseva, A. Yu. Kalinchuk, N. V. Krakhmal, N. M. Chernorubashkina, E. S. Martynova, R. A. Zukov, A. A. Gofman, A. B. Villert, O. N. Churuksaeva, L. A. Kolomiets, L. A. Tashireva
Publikováno v:
Опухоли женской репродуктивной системы, Vol 20, Iss 1, Pp 114-123 (2024)
Background. The inclusion of lenvatinib in the immunotherapy regimen for patients with MSS/pMMR endometrial cancer (EC) is due to its ability to modulate the tumor microenvironment, which allows the use of pembrolizumab in low-immunogenic tumors. How
Externí odkaz:
https://doaj.org/article/f6ff97e3ce1e4057a622dce54a5bf7d9
Autor:
Irina Larionova, Pavel Iamshchikov, Anna Kazakova, Militsa Rakina, Maxim Menyalo, Kadriia Enikeeva, Guzel Rafikova, Yuliya Sharifyanova, Valentin Pavlov, Alisa Villert, Larisa Kolomiets, Julia Kzhyshkowska
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Ovarian cancer (OC) is the most lethal gynecologic malignancy worldwide. The major clinical challenge includes the asymptomatic state of the disease, making diagnosis possible only at advanced stages. Another OC complication is the high relapse rate
Externí odkaz:
https://doaj.org/article/81c6117381f4454d8faa711578c75174
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 4, Pp 135-141 (2023)
Background. Ovarian cancer is the third most common cancer of the female reproductive system after cervical and uterine cancer and is diagnosed at stage III–IV in 2 out of 3 cases. Maintenance therapy with PARP inhibitors signifcantly prolongs dise
Externí odkaz:
https://doaj.org/article/a353383817cd4088bf927ebc18142760
Autor:
L. A. Kolomiets, M. N. Stakheeva, O. N. Churuksaeva, A. B. Villert, A. L. Chernyshova, V. G. Sisakyan, I. Yu. Lots, N. M. Chernorubashkina, V. N. Zhurman, A. A. Grechkina, E. N. Aleksandrova, N. E. Musaeva, O. V. Diduk, N. A. Bulygina, D. A. Pyatina, I. L. Obraz, A. V. Krechetova, M. A. Danilova, M. A. Khodzhakhova, A. A. Malsteva, N. A. Ermak
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 2, Pp 109-118 (2023)
Background. Endometrial cancer (EC) is one of the most significant oncogynecological problems. The main mortality cause in this disease, as in the case of other malignant neoplasms, is the tumor progression. The presence of mutations associated with
Externí odkaz:
https://doaj.org/article/ff8dd3121d334a85a54b0fbe8ef22913
Autor:
O. A. Ananina, L. A. Kolomiets, L. D. Zhuykova, O. N. Churuksaeva, A. L. Chernyshova, A. B. Villert, L. V. Pikalova, V. Yu. Mosolkov
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 1, Pp 120-128 (2023)
Background. The age-standardized cervical cancer incidence rate in the Tomsk region in 2021 was consistently higher than the average for the Russian Federation (21.2 / 100,000 versus 13.6 / 100,000 women). Primary prevention of cervical cancer is bes
Externí odkaz:
https://doaj.org/article/cec6056699254607b25a7b0d895b83c3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. B. Villert, I. A. Kolomiets, Y. A. Fesik, A. A. Ivanova, N. V. Yunusova, О. N. Churuksaeva
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 4, Pp 156-164 (2022)
Backgraound. High-grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer. The prevalence of BRCA1/2 germline mutations is the highest in HGSOC. patients with germline BRCA gene mutations are more likely to respond to platinu
Externí odkaz:
https://doaj.org/article/06ba19d2f0674e648dc01c8629529055
Autor:
M. A. Rakina, E. O. Kazakova, T. S. Sudaskikh, N. V. Bezgodova, A. B. Villert, L. A. Kolomiets, I. V. Larionova
Publikováno v:
Сибирский онкологический журнал, Vol 21, Iss 2, Pp 45-54 (2022)
Introduction. Ovarian cancer (OC) is the third most common gynecological cancer with the worst prognosis and highest mortality rate. The progression of OC can be accompanied by the detrimental functions of the components of the tumor microenvironment
Externí odkaz:
https://doaj.org/article/c5ba51d30c4d425183cc42d7927294e4
Publikováno v:
Сибирский онкологический журнал, Vol 20, Iss 1, Pp 162-168 (2021)
Background. Endometrial cancer is the most common malignancy of the female reproductive system. Patients with metastatic endometrial cancer have the overall 5-year survival rate of less than 20 %. The efficacy of treatment of advanced endometrial can
Externí odkaz:
https://doaj.org/article/20f3ab885c734839841ac9d269e69f50